GlassScriptPhysician profile
Henry Novack
NPI 1760460299
$1,971.73
in general payments reported to CMS, 2019-2025
17 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $922 · 2020: $471 · 2021: $154 · 2022: $166 · 2023: $103 · 2024: $52.17 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $257.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $433.26 | 2019-2022 | |
| Amgen INC. | $321.72 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $191.78 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $187.40 | 2019-2025 | Wainua, Lokelma |
| Amarin Pharma, INC. | $179.96 | 2019-2020 | |
| Pfizer INC. | $125.82 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $93.51 | 2019-2024 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $85.78 | 2019-2020 | |
| Boston Scientific Corporation | $66.45 | 2019 | |
| Sanofi-Aventis U.S. LLC | $65.55 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $49.05 | 2019 | |
| Medtronic, INC. | $39.77 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $39.09 | 2024 | Arcalyst |
| Kowa Pharmaceuticals America, INC. | $33.96 | 2019-2020 | |
| Heartflow, INC. | $27.62 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $18.38 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Novack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.